Matrix metalloproteinase 7 and perlecan in oral epithelial dysplasia and carcinoma in situ: An aid for histopathologic recognition of their cell proliferation centers

Journal of Oral Pathology and Medicine

Volumn 38, Issue 4, 2009, Pages 348-355

  Tilakaratne, W M ^a,b   Kobayashi, T ^a   Ida Yonemochi, H ^a   Swelam, W ^a   Yamazaki, M ^a   Mikami, T ^a   Alvarado, C G ^a   Shahidul, A Md ^a   Maruyama, S ^a   Cheng, J ^a   Saku, T ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b UNIVERSITY OF PERADENIYA   (Sri Lanka)

Author keywords

Carcinoma in situ; Epithelial dysplasia; MMP 7; Oral mucosa; Perlecan

Indexed keywords

GELATINASE A; INTERSTITIAL COLLAGENASE; MATRILYSIN; PERLECAN; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; BASEMENT MEMBRANE; CANCER SCREENING; CARCINOGENESIS; CARCINOMA CELL; CARCINOMA IN SITU; CELL PROLIFERATION; CHEEK MUCOSA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LOCALIZATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; MOUTH LESION; MOUTH MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; TONGUE;

CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DIAGNOSIS, DIFFERENTIAL; EPITHELIAL CELLS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 7; PRECANCEROUS CONDITIONS; TONGUE NEOPLASMS;

EID: 62949201788     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00750.x     Document Type: Article

References (47)

1. Pindborg JJ. Oral cancer and precancer. Bristol : John Write & Sons Ltd, 1980.
2. Pindborg JJ, Reibel J, Holmstrup P. Subjectivity in evaluating oral epithelial dysplasia, carcinoma in situ and initial carcinoma. J Oral Pathol 1985 14 : 698 708.
3. Brothwell DJ, Lewis DW, Bradley G, et al. Observer agreement in the grading of oral epithelial dysplasia. Community Dent Oral Epidemiol 2003 31 : 300 5.
4. Jordan RC, Macabeo-Ong M, Shiboski CH, et al. Overexpression of matrixmetalloproteinase-1 and -9 mRNA is associated with progression of dysplasia to cancer. Clin Cancer Res 2004 10 : 6460 5.
5. Warnakulasuriya S. Histological grading of oral epithelial dysplasia: revisited. J Pathol 2001 194 : 294 7.
6. Reibel J. Prognosis of oral premalignant lesions: significance of clinical, histopathological and molecular biological characteristics. Crit Rev Oral Biol Med 2003 14 : 47 62.
7. Massova I, Kotra LP, Fridman R, Mobashery S. Matrix metalloproteinases: structures, evolution, and diversification. FASEB J 1998 12 : 1075 95.
8. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001 17 : 463 516.
9. Curran S, Murray GI. Matrix metalloproteinases in tumour invasion and metastasis. J Pathol 1999 189 : 300 8.
10. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002 2 : 161 74.
11. Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med 2005 9 : 267 85.
12. Ikarashi T, Ida-Yonemochi H, Ohshiro K, Cheng J, Saku T. Intraepithelial expression of perlecan, a basement membrane-type heparin sulphate proteoglycan reflects dysplastic changes of the oral mucosal epithelium. J Oral Pathol Med 2004 33 : 87 95.
13. Saku T, Cheng J, Okabe H, Koyama Z. Immunolocalization of basement membrane molecules in the stroma of salivary gland pleomorphic adenoma. J Oral Pathol Med 1990 19 : 208 14.
14. Cheng J, Irié T, Munakata R, et al. Biosynthesis of basement membrane molecules by salivary adenoid cystic carcinoma cells. Virchows Arch 1995 426 : 577 86.
15. Kimura S, Cheng J, Toyoshima K, Oda K, Saku T. Basement membrane heparan sulfate proteoglycan (Perlecan) synthesized by ACC3, adenoid cystic carcinoma cells of human salivary gland origin. J Biochem 1999 25 : 406 13.
16. Kimura S, Cheng J, Ida H, Hao N, Fujimori Y, Saku T. Perlecan (heparan sulfate proteoglycan) gene expression reflected in the characteristic histological architecture of salivary adenoid cystic carcinoma. Virchows Arch 2000 437 : 122 8.
17. Ida-Yonemochi H, Ikarashi T, Nagata M, Hoshina H, Takagi R, Saku T. The basement membrane type heparan sulfate proteoglycan (perlecan) in ameloblastomas: its intercellular localization in stellate reticulum-like foci and biosynthesis by tumor cells in culture. Virchows Arch 2002 441 : 165 73.
18. Ida-Yonemochi H, Ohshiro K, Swelam W, Metwaly H, Saku T. Perlecan, a basement membrane type heparan sulfate proteoglycan, in the enamel organ: its intraepithelial localization in the stellate reticulum. J Histochem Cytochem 2005 53 : 763 72.
19. Wilson CL, Matrisian LM. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 1996 28 : 123 36.
20. Shiomi T, Okada Y. MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev 2003 22 : 145 52.
21. Yu WH, Woessner JF Jr. Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J Biol Chem 2000 275 : 4183 91.
22. Syafriadi M, Cheng J, Jen KY, Ida-Yonemochi H, Suzuki M, Saku T. Two-phase appearance of oral epithelial dysplasia resulting from focal proliferation of parabasal cells and apoptosis of prickle cells. J Oral Pathol Med 2005 34 : 140 9.
23. Working Committee of New Histopathological Criteria for Borderline Malignancies of the Oral Mucosa, Japanese Society for Oral Pathology. Guidelines for histopathological diagnosis of borderline malignancies of the oral mucosa. A preliminary proposal 2005. Niigata : Yamazaki Publishing, 2005.
24. Gale N, Westra W, Pilch BZ, et al. Epithelial precursor lesions. In : Barnes L, Eveson JW, Reichart P, Sidransky D, eds. World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. Lyon : IARC Press, 2005 177 9.
25. Syafriadi M, Ida-Yonemochi H, Ikarashi T, et al. Carcinoma in-situ of the oral mucosa has a definite tendency towards keratinization. Oral Med Pathol 2003 8 : 43 4.
26. The Working Committee on New Histopathological Criteria for Borderline Malignancies of the Oral Mucosa, Te Japanese Society for Oral Pathology. Oral CIS (JSOP) catalog: histopathological variations. Tokyo : Sunashobo Publishing Co Ltd, 2007 1 91.
27. Saku T, Furthmayr H. Characterization of the major heparan sulphate proteoglycan secreted by bovine aortic endothelial cells in culture. Homology to the large molecular weight molecule of basement membranes. J Biol Chem 1989 264 : 3514 23.
28. Yu WH, Woessner JF Jr., McNeish JD, Stamenkovic I. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev 2002 16 : 307 23.
29. Imai K, Yokohama Y, Nakanishi I, et al. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties. J Biol Chem 1995 270 : 6691 7.
30. Iozzo RV, Cohen IR, Grässel S, Murdoch AD. The biology of perlecan: the multifaceted heparan sulfate proteoglycan of basement membranes and pericellular matrices. Biochem J 1994 302 : 625 39.
31. Ohtani H, Nakamura S, Watanabe Y, Mizoi T, Saku T, Nagura H. Immunocytochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract. Lab Invest 1993 68 : 520 7.
32. Murata M, Hara K, Saku T. Dynamic distribution of basic fibroblast growth factor during epulis formation: an immunohistochemical study in an enhanced healing process of the gingiva. J Oral Pathol Med 1997 26 : 224 32.
33. Yamazaki M, Cheng J, Hao N, et al. Basement membrane-type heparan sulfate proteoglycan (perlecan) and low-density lipoprotein (LDL) are co localized in granulation tissues: a possible pathogenesis of cholesterol granulomas in jaw cysts. J Oral Pathol Med 2004 33 : 177 84.
34. Utsunomiya H, Tilakaratne WM, Oshiro K, et al. Extracellular matrix remodeling in oral submucous fibrosis its stage-specific modes revealed by immunohistochemistry and in situ hybridization. J Oral Pathol Med 2005 34 : 498 507.
35. Pindborg JJ, Reichart PA, Smith CJ, van der Waal I. World Health Organization international histological classification of tumours. Histological typing of cancer and precancer of the oral mucosa, 2nd edn. Berlin : Springer-Verlag, 1997.
36. Noë V, Fingleton B, Jacobs K, et al. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 2001 114 : 111 8.
37. Borchers AH, Sanders LA, Bowden GT. Regulation of matrilysin expression in cells of squamous cell carcinoma by E-cadherin-mediated cell-cell contact. J Cancer Res Clin Oncol 1997 123 : 13 20.
38. Yamamoto H, Adachi Y, Itoh F, et al. Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res 1999 59 : 3313 6.
39. Ohashi K, Nemoto T, Nakamura K, Nemori R. Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas. Cancer 2000 88 : 2201 9.
40. Yamashita K, Mori M, Shiraishi T, Shibuta K, Sugimachi K. Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma. Clin Cancer Res 2000 6 : 1169 74.
41. Tanioka Y, Yoshida T, Yagawa T, et al. Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer. Br J Cancer 2003 89 : 2116 21.
42. Kawano N, Osawa H, Ito T, et al. Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study. Hum Pathol 1997 28 : 613 22.
43. Zhang J, Jin X, Fang S, et al. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis 2005 26 : 1748 53.
44. Bair EL, Massey CP, Tran NL, et al. Integrin-and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocultures of malignant oral squamous cell carcinoma cells and dermal fibroblasts. Exp Cell Res 2001 270 : 259 67.
45. Impola U, Uitto VJ, Hietanen J, et al. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell caner. J Pathol 2004 202 : 14 22.
46. Nagata M, Fujita H, Ida H, et al. Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis. Int J Cancer 2003 106 : 683 9.
47. Sutinen M, Kainulainnen T, Hurskainen T, et al. Expression of matrix metalloproteinases (MMP-1 and 2) and their inhibitors (TIMP-1, 2 and 3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Br J Cancer 1998 77 : 2239 45.